» Authors » Koichi Yamaguchi

Koichi Yamaguchi

Explore the profile of Koichi Yamaguchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 414
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamikubo Y, Nagaya S, Inoue R, Yamaguchi K, Morimoto-Kamata R, Morishita E, et al.
Thromb Haemost . 2025 Mar; PMID: 40049601
Background And Objectives: Initial thrombin (FIIa) generated via the tissue factor (TF) pathway plays a crucial role in amplifying coagulation. There is growing evidence that the TF pathway might contribute...
2.
Bae S, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, et al.
Rheumatology (Oxford) . 2024 Sep; PMID: 39222437
Objective: The 6-min walk test (6MWT) is a simple test widely used to assess sub-maximal exercise capacity in chronic respiratory diseases. We explored the relationship of 6-min walk distance (6MWD)...
3.
Yamaguchi K, Poland P, Zhu L, Moghadam-Kia S, Aggarwal R, Maeno T, et al.
Rheumatology (Oxford) . 2024 Aug; PMID: 39186037
Objectives: Anti-melanoma differentiation-associated gene 5 antibody-positive (MDA5+) dermatomyositis patients exhibit clinical features that vary by geographical and ethnic/genetic distribution. We therefore investigated whether B cell epitope profiles and corresponding clinical...
4.
Kishi R, Nakano R, Nakano A, Harimoto T, Taniguchi R, Ando S, et al.
JAC Antimicrob Resist . 2024 Aug; 6(4):dlae135. PMID: 39165366
Objectives: Despite the global health risk of carbapenem-resistant Enterobacterales (CRE), especially carbapenemase-producing Enterobacterales (CPE), Japan reports a significantly low frequency of CRE with a predominance of IMP-type carbapenemases. This study...
5.
Yamaguchi K, Tang Q, LaConti J, Kippelen F, Zhu L, Poland P, et al.
ACR Open Rheumatol . 2024 Jul; 6(10):615-624. PMID: 38973625
Objective: Anti-histidyl-transfer RNA synthetase (Jo-1) antibodies are associated with myositis as well as different extramuscular organ complications comprising the anti-synthetase syndrome. This study aimed to clarify the relationship between anti-Jo-1...
6.
Yamaguchi K, Tang Q, Poland P, Reay D, Gregory A, Aggarwal R, et al.
Front Immunol . 2024 Jun; 15:1399451. PMID: 38895121
Introduction: Anti-SSA antibodies target two unrelated proteins, Ro52 (E3 ligase) and Ro60 (RNA binding protein). Previous studies indicate that anti-Ro52 antibodies are frequently associated with various myositis-specific autoantibodies (MSAs)-including anti-tRNA...
7.
Takehara K, Koga Y, Hachisu Y, Utsugi M, Sawada Y, Saito Y, et al.
Respir Investig . 2024 Mar; 62(3):388-394. PMID: 38460356
Background: The antifibrotic agents pirfenidone and nintedanib have been shown to be effective in patients with idiopathic pulmonary fibrosis (IPF). However, discontinuation of antifibrotic drugs is a major clinical concern...
8.
Kuribayashi S, Nakamura F, Motegi S, Hara K, Hosaka H, Sekiguchi A, et al.
J Gastroenterol . 2024 Jan; 59(3):179-186. PMID: 38252140
Backgrounds: Patients with systemic sclerosis (SSc) often have esophageal motility abnormalities and weak esophago-gastric junction (EGJ) barrier function, which causes proton pump inhibitor (PPI)-refractory reflux esophagitis (RE). The aims of...
9.
Togashi T, Nagaya S, Meguro-Horike M, Matsumoto H, Imai Y, Yamaguchi K, et al.
Thromb Res . 2023 Nov; 233:37-40. PMID: 37995440
No abstract available.
10.
Yamaguchi K, Poland P, Bijoy George T, Saygin D, Moghadam-Kia S, Aggarwal R, et al.
Rheumatology (Oxford) . 2023 Oct; 63(7):2016-2023. PMID: 37815819
Objectives: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (MDA5+) dermatomyositis patients exhibit a variety of clinical features. We therefore investigated whether patterns of B-cell epitope recognition are linked to the clinical...